Although the cancer-related roles of these novel MSI targets are largely unknown, it has been shown that siRNA-mediated inhibition of ALPK2 inhibits apoptosis30, suggesting that the functional implication of these novel, recurrent MSI events warrants further investigation. Here, ALPK2 is linked to cancer.